While Ozempic also bestowed 47% relative risk reduction to women, other GLP-1 receptor agonists slightly outperformed Ozempic in men (14% relative Alzheimer's disease risk).

The study compared Semaglutide (Commercially: Ozempic for diabetes, Wegovy for weight-loss) against 7 other type 2 diabetes medications for its ability to prevent Alzheimer's disease in older type 2 diabetes patients, a critical group with 65% higher risk for developing…

Ozempic outperformed every other type 2 diabetes medication in preventing Alzheimer's disease, with a 78% and 52% risk reduction compared to insulin, in women and men, respectively.

Ozempic surpasses all other diabetes medications in preventing Alzheimer's disease in diabetics >60 years, effect is more pronounced in women, and independent of obesity.

A recently published article in Alzheimer & Dementia (1) reported 7 target trial emulations (a highly standardized type of retrospective observational studies) analyzing the data of over 1 million type 2 diabetes patients over 60 (over 116 million Electronic Health Records EHRs…

@elonmusk @neuralink Agreed, a great application for the tech

In Miami this week with heretics and health nuts. What if they had a baby?

Pretty soon, we’ll find out that thinking without the aid of AI will feel rather limiting.

@TheGregYang 💀😂

There are two kinds of people: those who don’t want the day to end and those who can’t wait for the morning to arrive.